查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1521027

输液袋市场 – 2024 年至 2029 年预测

IV Bags Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计输液袋市场在预测期内将以 6.13% 的年复合成长率(CAGR)成长，并从 2024 年的估计值40.61 亿美元增加到 2029 年达到 54.67 亿美元。

机动车事故是全球残疾和死亡的主要原因之一，每年造成 5,000 万人受伤、130 万人死亡。据世界卫生组织 (WHO) 称，全球整体四分之一的死亡与步行或骑自行车有关。因此，越来越多的手术和事故将需要静脉输液，这预计将刺激市场扩张。

慢性病盛行率的增加和老年人口的增加对市场动态产生了重大影响。此外，该地区不断增长的医疗保健支出和严格的患者安全监管政策预计将在预测期内增加对厨房设备的需求。然而，由于手术治疗的预期增加，预计市场将稳定上涨。

慢性病盛行率的增加预计将推动市场成长。

慢性病盛行率上升、手术和道路事故数量增加以及老年人口增加等因素预计将在预测期内推动市场成长。输液袋市场需求的主要驱动因素是癌症、神经系统疾病和胃肠道疾病等慢性病的盛行率上升。

例如，根据美国国立卫生研究院2022年7月的数据，截至2022年，北美和欧洲等西方地区约20%的人将患有胃食道逆流（GERD）。此外，美国的 GERD 优势从 18.1% 扩大到 27.8%。

此外，《2023 年癌症现实与数字》报告中的资讯预测，到 2023 年，美国将有 297,790 名女性被诊断出乳癌，高于 2022 年的 287,850 名当代病例。此外，据同一资讯来源称，预计到 2023 年，美国将有约 55,720 名女性被原位诊断出乳癌，而 2022 年这一数字为 51,400 例。由于癌症治疗会剥夺身体的营养并导致溃疡、胃肠功能障碍和身体阻塞，从而影响身体，因此对静脉输液袋的需求预计将会增加。接受肠外营养的患者日益增长的需求将推动市场扩张。

医院部门预计将推动市场成长。

越来越多的医院管理的需要静脉注射治疗的疾病增加了医院对静脉注射袋的需求。慢性病的增加也推动了全球对静脉注射袋的需求。

随着癌症手术和器官移植手术的增加，在移植手术期间和之后需要静脉输液，静脉输液袋预计在未来几年在医院领域将会成长。根据卫生资源与服务管理局organdonor.gov统计，截至2024年3月，美国进行了27,332例肾臟移植手术、10,660例肝臟移植手术、102例胰臟移植手术、812例心臟移植手术和4,545例肺移植手术。增加新产品的推出和监管部门的核准也推动了市场的成长。

随着人口老化和慢性病的盛行率上升，医院对输液袋的需求将会增加。此外，不断增加的产品推出和推广从全国各地医院收集的输液袋的回收也推动了输液袋市场的发展。

例如，2023 年 12 月，百特国际与芝加哥西北医学院合作，完成了美国医院静脉输液袋回收计画试点的初始阶段。超过 6 吨的 PVC IV 袋废弃物从垃圾掩埋场转入回收再生用。同样，2023 年 2 月，新加坡大型三级医院 NUH 发起了新加坡首个输液袋回收倡议。

预计北美地区市场将成长。

在美国和加拿大等新兴经济体，慢性病的流行预计将提振市场。医疗保健支出的成长趋势加上人口老化的加剧将对静脉输液袋的需求产生重大影响。美国癌症患者数量的增加也反映出静脉输液袋需求增加的潜在需求前景。例如，根据美国癌症协会的数据，预计2023年新患者人数将达到1,958,310人，其中男性1,010,310人，女性948,000人，相较之下，同年预计死亡人数达到609,820人。

主要市场发展：

  • 2023 年 2 月，Bowmed Ibisqus 推出了 Ready to Administer IV 左氧氟沙星 500mg/100ml 袋装。该袋子采用铝箔外包装，可避光并显示产品资讯。新产品已在 AAH 註册，代码为 LEV0316T。因此，未来几年的市场扩张可能会受到医院对静脉输液袋日益依赖的推动。

主要参与者

  • Sippex 是 PVC 和多层袋及连接器的领先製造商。我们专注于医疗袋和连接器的设计和製造，为製药和医疗解决方案提供创新的软质包装，包括静脉输液袋和连接器。 SIPPEX 提供高性能机械和 30 年的塑胶加工专业知识。
  • Technoflex 是欧洲领先的输注药物输送袋和连接器设计、製造和商业化公司，并获得 FDA 和 EMEA 认证。 Technoflex 拥有 40 多年的经验，与领先的製药实验室合作，推出创新技术，改进包装并使看护者更容易处理注射剂。
  • Metrix 公司是美国医疗设备製造商，产品包括血袋、输血过滤器、静脉输液器、PVC 和 EVA 容器、腔室、双袋和配件。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章 箱包市场：依材料类型

  • 介绍
  • PVC
  • PP
  • PE

第六章 IV 箱包市场：依容量分类

  • 介绍
  • 小于100毫升
  • 100～250ml
  • 250～500ml
  • 500～1000ml
  • 1000ml以上

第七章 箱包市场：依箱型分类

  • 介绍
  • 单室
  • 多室

第八章 箱包市场：依最终用户分类

  • 介绍
  • 血库
  • 医院
  • 门诊服务

第九章 箱包市场：依地区划分

  • 介绍
  • 北美洲
    • 依材料类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 依材料类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 依材料类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 依材料类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 依材料类型
    • 按容量
    • 按腔室类型
    • 按最终用户
    • 按国家/地区

第十章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十一章 公司简介

  • Sippex
  • Kraton Corporation
  • Renolit Solmed
  • Alfa Laboratories
  • Polycine GmbH
  • Haemotronic SPA
  • Hospira Inc.
  • Technoflex SA
  • The Metrix Company
  • Medicopack A/S
  • Wipak Group
  • Qosina Corporation
简介目录
Product Code: KSI061612706

The IV bags market is anticipated to grow at a compound annual growth rate (CAGR) of 6.13% over the forecast period to reach US$5.467 billion by 2029, increasing from estimated value of US$4.061 billion in 2024.

The supply of plastic materials needed for intravenous therapy with important applications in hospital care defines the global market for IV bags, which has graduated as a key segment within the field of parental packaging. Electrolyte depletion is uncommon in individuals with fever and diarrhea. Lack of hydration, which is more common in children, is too brought on by this and can become serious. Moreover, IV packs are becoming progressively prevalent and favored alternatives for parenteral bundling due to their simple accessibility. The cost of an IV sack is roughly $1, which significantly contributes to the market's rising deals.

Car crashes are one of the leading causes of disability and death worldwide, resulting in up to 50 million injuries and 1.3 million fatalities annually. Across the globe, one in every four deaths is related to walking or bicycling, based on the World Health Organization. Fluid administration is therefore required due to the rising number of surgeries and accidents, which is anticipated to spur market expansion.

Market dynamics have been greatly affected by the growing prevalence of chronic disease and the increasing geriatric population. Furthermore, an increase in healthcare spending in the region and strict regulatory policies for patient safety are expected to increase the kitchen appliance demand in the forecast period. However, with projections of growing surgical treatment, the market is expected to rise steadily.

The increasing prevalence of chronic diseases is anticipated to propel market growth.

Factors such as the rising prevalence of chronic diseases, the increased number of surgeries and road accidents, and the growing geriatric population are expected to drive market growth during the forecast period. The primary driver of the market's demand for IV bags is the rising prevalence of chronic illnesses like cancer, neurological disorders, and gastrointestinal disorders.

For instance, according to the National Institute of Health in July 2022 stated that around 20% of individuals in western locales, such as North America and Europe, have gastroesophageal reflux illness (GERD) as of 2022. Besides, the predominance of GERD in the US extended from 18.1% to 27.8%

Furthermore, information from the Cancer Realities and Figures 2023 report demonstrates that 297,790 ladies in the US are expected to get an obtrusive breast cancer conclusion in 2023, up from 287,850 modern cases in 2022. Additionally, the same source states that in 2023, compared to 51,400 cases in 2022, approximately 55,720 women in the US are anticipated to receive a non-invasive (in situ) breast cancer diagnosis. Since cancer treatment deprives the body of nutrition and affects the body by causing ulcers, gastrointestinal dysfunction, and physical blockages, it is anticipated that the demand for IV bags will increase. It increases the need for patients to receive parenteral nutrition, which drives market expansion.

The hospitals segment is anticipated to propel market growth.

The increase in medical conditions that need hospital administration, which requires IV therapy, has bolstered the demand for IV bags in hospitals. The rise in the prevalence of chronic disease also drives the demand for IV bags globally.

Increasing cancer surgeries as well as organ transplant procedures also demand infusing intravenous fluids both during and after the completion of transplant surgery, which will lead to the growth of IV bags in the hospital sector in the coming years. As per Health Resources & Services Administration, organdonor.gov, the transplant performed by organs in the U.S. of kidney, liver, pancreas, heart, and lungs were 27,332, 10,660, 102, 812, and 4,545 respectively, as of March 2024. Additionally, Increasing launches of new products and approvals from the regulatory bodies also drive the growth of the market.

The demand for IV bags in hospitals will increase with the growing aging population, and rise in the prevalence of chronic diseases. Additionally, rising product launches and recycling drives of IV bags collected from hospitals across the country also drive the market for IV bags.

For instance, in December 2023, Baxter International completed the initial phase of its intravenous bag recycling program pilot for U.S. hospitals, partnering with Northwestern Medicine in Chicago. Over six tons of PVC IV bag waste were diverted from landfills for recycling. Similarly, in February 2023, NUH, a large tertiary hospital in Singapore, initiated Singapore's first IV fluid bag recycling drive.

The market is projected to grow in the North American region.

The growing prevalence of chronic diseases is anticipated to boost the market in developed economies such as the United States and Canada among others. The increasing trend of healthcare spending coupled with the enlargement of the geriatric population will have a significant impact on the demand for IV bags. The rising burden of cancer cases in the United States also reflects potential demand prospects in the growth in demand for IV bags. For instance, as per the American Cancer Society, Inc, the Estimated New Cases in 2023 reached 1,958,310, comprising 1,010,310 for males and around 948,000 for females whereas the Estimated Deaths reached 609,820 in the same year.

Key Market Developments:

  • In February 2023, Bowmed Ibisqus launched a Ready to Administer IV Levofloxacin 500mg/100ml Bag, offering a convenient and efficient dose form. The bag is packaged with a foil overwrap to protect it from light and displays product information. The new product line is listed with AAH under code LEV0316T. Consequently, the market's expansion in the upcoming years will be driven by the increasing reliance on IV bags in hospitals.

Key Players:

  • Sippex is a leading manufacturer of PVC and multilayer bags and connectors. They are specialized in designing and manufacturing medical bags and connectors, offering innovative flexible packaging for pharmaceutical and medical solutions, including IV bags and connectors. SIPPEX offers high-performance machinery and 30 years of expertise in plastic processing. Vertically integrated, the corporation controls all technologies involved in the production process, from raw materials to completed goods.
  • Technoflex is a leading European company in designing, producing, and commercializing I.V. drug delivery bags and connectors, with FDA and EMEA references. With over 40 years of experience, Technoflex has collaborated with major pharmaceutical laboratories and introduced innovations to improve packaging, facilitating caregivers' manipulation of injectable products.
  • The Metrix Company is a US-based manufacturer of medical devices like blood bags, transfusion filters, IV sets, PVC and EVA containers, chambers, dual bags, and accessories.

Segmentation:

By Material Type

  • PVC
  • PP
  • PE

By Capacity

  • Less than 100 ml
  • 100-250 ml
  • 250-500 ml
  • 500-1000 ml
  • Above 1000 ml

By Chamber Type

  • Single Chamber
  • Multi Chamber

By End-User

  • Blood Banks
  • Hospitals
  • Ambulatory Services

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. IV BAGS MARKET BY MATERIAL TYPE

  • 5.1. Introduction
  • 5.2. PVC
  • 5.3. PP
  • 5.4. PE

6. IV BAGS MARKET BY CAPACITY

  • 6.1. Introduction
  • 6.2. Less than 100 ml
  • 6.3. 100-250 ml
  • 6.4. 250-500 ml
  • 6.5. 500-1000 ml
  • 6.6. Above 1000 ml

7. IV BAGS MARKET BY CHAMBER TYPE

  • 7.1. Introduction
  • 7.2. Single Chamber
  • 7.3. Multi Chamber

8. IV BAGS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Hospitals
  • 8.4. Ambulatory Services

9. IV BAGS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Material Type
    • 9.2.2. By Capacity
    • 9.2.3. By Chamber Type
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. United States
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Material Type
    • 9.3.2. By Capacity
    • 9.3.3. By Chamber Type
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Material Type
    • 9.4.2. By Capacity
    • 9.4.3. By Chamber Type
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. Germany
      • 9.4.5.2. United Kingdom
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Material Type
    • 9.5.2. By Capacity
    • 9.5.3. By Chamber Type
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Material Type
    • 9.6.2. By Capacity
    • 9.6.3. By Chamber Type
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. South Korea
      • 9.6.5.4. India
      • 9.6.5.5. Thailand
      • 9.6.5.6. Indonesia
      • 9.6.5.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Sippex
  • 11.2. Kraton Corporation
  • 11.3. Renolit Solmed
  • 11.4. Alfa Laboratories
  • 11.5. Polycine GmbH
  • 11.6. Haemotronic S.P.A.
  • 11.7. Hospira Inc.
  • 11.8. Technoflex S.A.
  • 11.9. The Metrix Company
  • 11.10. Medicopack A/S
  • 11.11. Wipak Group
  • 11.12. Qosina Corporation